Eight Capital downgraded shares of Cronos Group (TSE:CRON) from a buy rating to a neutral rating in a research note issued to investors on Thursday. Eight Capital currently has C$24.00 price objective on the stock, up from their previous price objective of C$16.00.
A number of other equities research analysts have also recently weighed in on the company. Cowen reaffirmed a market perform rating and set a C$29.00 price target on shares of Cronos Group in a report on Tuesday, March 5th. Jefferies Financial Group reaffirmed an underperform rating and set a C$17.00 price target on shares of Cronos Group in a report on Monday, February 25th. CIBC reaffirmed an outperform rating and set a C$22.00 price target on shares of Cronos Group in a report on Friday, January 18th. Cormark raised their price target on Cronos Group from C$10.00 to C$17.00 in a report on Monday, December 10th. Finally, GMP Securities raised their price target on Cronos Group from C$14.00 to C$24.00 in a report on Monday, December 10th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of C$21.43.
Cronos Group stock opened at C$29.15 on Thursday. The company has a quick ratio of 5.74, a current ratio of 9.02 and a debt-to-equity ratio of 2.58. The company has a market cap of $5.06 billion and a P/E ratio of -883.33. Cronos Group has a one year low of C$6.57 and a one year high of C$32.95.
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations ?MMPR?. The firm typically invests in companies based in Canada.
Further Reading: Liquidity
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.